Skip to main content

Table 2 Overview over relative expression of p53 isoforms in individual patients together with progression free-survival

From: High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma

Patient ID Δ133p53ratio p53βratio p53γratio Progression free- survival (months)
1 67.16 6.05 .86 29
2 19.17 4.90 0 0
3 187.50 17.35 0 0
4 19.87 0 0 14
5 0 0 0 7
6 17.21 0 0 1
7 42.31 17.08 27.85 3
8 234.46 0 0 14
9 22.37 0 2.63 10
10 5.16 .79 .57 5
11 9.47 6.35 0 58
12 7.93 1.68 .29 96
13 2.81 .27 .45 25
14 2.65 .67 .66 11
15 4.60 3.23 1.02 11
16 6.78 3.60 1.35 2
17 2.26 1.30 .74 0
18 5.75 2.10 .93 2
19 10.55 3.09 1.56 19
20 28.51 1.48 2.14 0
21 28.63 18.59 7.90 1
22 19.20 2.52 .54 31
23 35.80 18.67 5.20 15
24 33.33 2.89 .34 43
25 36.17 4.86 4.62 0
26 97.55 60.37 3.39 0
27 10.57 5.58 1.44 1
28 6.16 .98 .48 4
29 42.70 8.18 2.23 48
30 10.28 4.42 .61 28
31 60.74 0 0 11
32 38.58 5.87 2.71 0
33 10.13 2.66 2.23 0
34 85.68 0 0 11
35 7.51 0 1.94 15
36 25.74 7.85 1.64 6
37 32.86 13.85 6.09 0